Caitlin Cantando
Family · Fresno, CANPI 1568117851
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 110 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Mayne Pharma Commercial LLC at 26.5% of the total. Reporting peaked in 2024 at $813 and has fallen 52.0% since, to $390 in 2025.
Across 110 payments — averaging $18.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mayne Pharma Commercial LLC$552
- Galderma Laboratories, L.p.$308
- Shield Therapeutics Inc$286
- AbbVie$285
- Exeltis, USA Inc.$107
- Organon$92
- plus $449 from 10 others
What the payments were for
- Food & beverage$2,080100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mayne Pharma Commercial LLC | 46 | $552 |
| Galderma Laboratories, L.p. | 6 | $308 |
| Shield Therapeutics Inc | 16 | $286 |
| AbbVie | 11 | $285 |
| Exeltis, USA Inc. | 5 | $107 |
| Organon | 4 | $92 |
| Agile Therapeutics, Inc. | 4 | $86 |
| Myovant Sciences Inc. | 4 | $73 |
| Bayer | 3 | $61 |
| Sage Therapeutics, LLC | 3 | $58 |
| Daiichi Sankyo Inc. | 2 | $42 |
| Pfizer | 2 | $35 |
| BD | 1 | $29 |
| Hologic Sales And Service, LLC | 1 | $24 |
| Astellas Pharma US Inc | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
How this compares
$2,080 in reported general payments places this provider in the 85th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 117 | $4,745 |
| Estradiol-Norethindrone AcetatEstradiol/Norethindrone Acet | 24 | $1,007 |
| Estradiol (Twice Weekly)Estradiol | 12 | $993 |
| ProgesteroneProgesterone, Micronized | 11 | $802 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 11 | $91 |
| Fluconazole | 11 | $53 |
Paid to pharmacies, not to this prescriber.
Other family in Fresno
- Freddy EspinozaFresno$33K
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Erin DwyerSan Diego$189K
- Phyllis CasonLos Angeles$187K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.